{"gene":"MAPKAPK2","run_date":"2026-06-10T02:59:50","timeline":{"discoveries":[{"year":2015,"finding":"mTOR controls SASP by differentially regulating translation of MAPKAPK2 (MK2) through 4EBP1; activated MK2 then phosphorylates the RNA-binding protein ZFP36L1 during senescence, inhibiting its ability to degrade transcripts of SASP components.","method":"Drug screen, genetic rescue, mTOR inhibitor rapamycin treatment, overexpression of constitutively active ZFP36L1, phosphorylation assays","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (drug screen, genetic rescue, phosphorylation assays) identifying MK2 substrate ZFP36L1 and upstream regulator 4EBP1/mTOR","pmids":["26280535"],"is_preprint":false},{"year":2017,"finding":"MK2 directly phosphorylates RIPK1 at serine 321 in the TNF signaling pathway, inhibiting RIPK1 kinase activation, blocking its ability to bind FADD/caspase-8, and suppressing RIPK1-dependent apoptosis and necroptosis; a phospho-mimetic S321D RIPK1 mutation limits TNF-induced death.","method":"In vitro kinase assay, phospho-mimetic mutagenesis (S321D), Co-IP, cell death assays","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct in vitro phosphorylation assay, mutagenesis, replicated across three independent labs (PMIDs 28506461, 28920954, 28920952)","pmids":["28506461","28920954","28920952"],"is_preprint":false},{"year":2002,"finding":"MK2 is activated by p38 MAPKα and -β, which bind to a basic docking motif in the C terminus of MK2 and phosphorylate its regulatory sites; upon activation, MK2 is exported from nucleus to cytoplasm and cotransports active p38 MAPK. MK2 stabilizes p38 MAPK protein levels through its C terminus (independent of catalytic activity). TNF biosynthesis requires MK2 catalytic activity. Cell migration requires both MK2 catalytic activity and its proline-rich N-terminal region.","method":"MK2 knockout macrophages and MEFs, MK2 isoform/mutant reconstitution, p38 MAPK protein level measurement, TNF production assay, cell migration assay on fibronectin","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout with reconstitution of multiple MK2 mutants, multiple orthogonal readouts (p38 stabilization, TNF biosynthesis, migration)","pmids":["12052889"],"is_preprint":false},{"year":2012,"finding":"MK2 phosphorylates tristetraprolin (TTP) at S52/S178, decreasing TTP's affinity to AU-rich elements (AREs), inhibiting TTP's ability to replace HuR on target mRNAs, and permitting HuR-mediated initiation of translation of TNF mRNA; this exchange between TTP and HuR provides a reversible switch between unstable/non-translatable and stable/efficiently translated mRNAs.","method":"ARE reporter assays, TTP/HuR binding experiments, phosphorylation-site mutagenesis, MK2 knockout macrophages","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 1 / Strong — biochemical reconstitution of TTP-HuR exchange, phosphorylation site mutagenesis, genetic knockout validation","pmids":["23028373"],"is_preprint":false},{"year":2015,"finding":"MAPKAPK2 (MK2) and MAPKAPK3 (MK3) phosphorylate Beclin 1 at serine 90 to positively regulate starvation-induced autophagy; BCL2 blocks MK2/MK3-dependent Beclin 1 S90 phosphorylation and thereby inhibits autophagy.","method":"In vitro kinase assay, phospho-site mutagenesis, autophagy flux assays in vitro and in vivo, BCL2 co-expression experiments","journal":"eLife","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct in vitro phosphorylation of Beclin 1 by MK2, mutagenesis of S90, validated in vivo","pmids":["25693418"],"is_preprint":false},{"year":2015,"finding":"MK2 activity is required for the p38-driven induction of miR-34c following DNA damage; miR-34c in turn represses c-Myc translation to prevent inappropriate DNA replication. In p53-deficient cells, the p38 MAPK/MK2 pathway drives miR-34c induction.","method":"MK2 inhibition/knockdown, miR-34c induction measurement, S-phase arrest assays, c-Myc depletion epistasis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological and genetic inhibition of MK2, miRNA epistasis, single lab with multiple readouts","pmids":["20212154"],"is_preprint":false},{"year":2007,"finding":"Crystal structure of the MK2 kinase domain in complex with a high-affinity inhibitor (IC50 8.5 nM) was determined in two crystal forms, revealing conformational flexibility in the binding site and a potential intermediate state during substrate phosphorylation.","method":"X-ray crystallography (soaking and co-crystallization), two crystal forms","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure determination in two independent crystal forms with functional implications for substrate binding","pmids":["17449059"],"is_preprint":false},{"year":2007,"finding":"Crystal structure of MK2 kinase domain with pyrrolopyridine inhibitor class defined the ATP binding site and provided structural basis for selective inhibition; inhibitors suppress TNF-α production and show efficacy in acute inflammation models.","method":"X-ray crystallography of MK2/inhibitor complex, in vitro kinase assays, cellular TNF-α suppression assays","journal":"Journal of medicinal chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure of MK2-inhibitor complex, biochemical and cellular validation","pmids":["17480064"],"is_preprint":false},{"year":2011,"finding":"MK2 phosphorylates PDE4A5 at Ser147 within the UCR1 domain; this phosphorylation does not alter PDE4A5 basal activity but markedly attenuates PDE4A5 activation by protein kinase A, amplifying intracellular cAMP accumulation. MK2 phosphorylation also triggers a conformational change in PDE4A5 that disrupts its interaction with DISC1 and AIP.","method":"In vitro kinase assay, phosphorylation site mutagenesis, MK2/3-null macrophage reconstitution, cAMP accumulation assays, co-IP for protein interactions","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct in vitro kinase assay with mutagenesis, validated in MK2/3-null primary macrophages, multiple orthogonal readouts","pmids":["21323643"],"is_preprint":false},{"year":2015,"finding":"MK2 phosphorylates CEP131 at S47 and S78 following UV-induced stress; phosphorylation creates direct binding sites for 14-3-3 proteins, which sequester CEP131 in the cytoplasm, blocking formation of new centriolar satellites and causing rapid depletion of these structures.","method":"Phosphoproteomics, in vitro kinase assay, phospho-site mutagenesis of CEP131, 14-3-3 binding assays, live-cell imaging of centriolar satellite remodeling","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro kinase assay, phospho-site mutagenesis, direct 14-3-3 binding, functional centriolar satellite imaging","pmids":["26616734"],"is_preprint":false},{"year":2018,"finding":"MK2 phosphorylates the RNA-binding subunit of the NELF complex, NELFE, at Serine 115 following UV-induced DNA damage; NELFE phosphorylation promotes recruitment of 14-3-3 proteins and rapid dissociation of the NELF complex from chromatin, accompanied by RNA polymerase II elongation.","method":"Quantitative phosphoproteomics, kinase inhibition, in vitro phosphorylation, 14-3-3 binding assays, chromatin fractionation, RNA Pol II elongation assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Moderate — quantitative phosphoproteomics, direct kinase assay, 14-3-3 binding, chromatin dissociation assays in single comprehensive study","pmids":["29523821"],"is_preprint":false},{"year":2010,"finding":"MK2 directly phosphorylates keratins K18 at Ser52 and K20 at Ser13 in vitro and in vivo; p38 directly phosphorylates K8-Ser73; MK2 and p38 cooperate to phosphorylate epithelial keratins in intestinal epithelia, and MK2-dependent K20-Ser13 phosphorylation regulates mucin secretion.","method":"Phosphoproteomics, in vitro kinase assays, MK2/3 knockout mouse cells, small molecule inhibitors, MK2 knockdown in HT29 cells, mucin secretion assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct in vitro kinase assays, validated in MK2/3 KO mouse ileum and MK2 knockdown cells, multiple orthogonal approaches","pmids":["20724476"],"is_preprint":false},{"year":2009,"finding":"MAPKAPK2 functions in the yolk cell downstream of p38 MAPK to regulate epiboly during zebrafish development by modulating F-actin network activity at the yolk cell margin; loss-of-function (betty boop mutant) causes premature constriction of an F-actin network and blastoderm margin constriction at 50% epiboly.","method":"Positional cloning, whole-blastoderm transplants, mRNA microinjection rescue, p38 inhibitor epistasis, calcium imaging, F-actin visualization","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — positional cloning of maternal-effect mutant, rescue by mRNA injection, epistasis with p38 inhibitor, multiple orthogonal methods","pmids":["19282986"],"is_preprint":false},{"year":2006,"finding":"MK2-dependent phosphorylation of Hsp25 (Ser86) is required for stress-induced disaggregation and insolubilization of Hsp25 oligomers; in MK2-deficient fibroblasts, Hsp25 insolubilization is delayed, 14-3-3 binding is absent, and cells show increased resistance to arsenite, H2O2, and sublethal heat shock. MK2 phosphorylation of Hsp25 correlates with stress-induced cell damage under sublethal conditions.","method":"MK2 knockout fibroblasts, in vitro phosphorylation, 14-3-3 binding assays, GFP-Hsp25 imaging, apoptosis assays, solubility fractionation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout with in vitro biochemistry, multiple stress conditions, imaging and biochemical fractionation","pmids":["16840785"],"is_preprint":false},{"year":2010,"finding":"MK2 phosphorylates LSP1 at Ser243 (murine)/Ser252 (human), the major phosphorylation site in its C-terminal F-actin binding region; phosphorylated LSP1 localizes to F-actin-enriched lamellipodia and stabilizes F-actin polarization during neutrophil chemotaxis toward fMLP. MK2-/- neutrophils show only transient rather than persistent F-actin polarization.","method":"Phospho-site mutagenesis, phospho-specific antibody generation, immunostaining, F-actin polarization assays in WT and MK2-/- neutrophils, p38 inhibitor SB203580","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — phospho-site mutagenesis and knockout validated in primary neutrophils, single lab","pmids":["17481585"],"is_preprint":false},{"year":2010,"finding":"MK2 SUMOylation at lysine K339 (by TNF-α stimulus) inhibits MK2 kinase activity and limits HSP27 phosphorylation; loss of the SUMOylation site (MK2-K339R) increases kinase activity, prolongs HSP27 phosphorylation, enhances actin filament remodeling, and alters endothelial cell migration.","method":"SUMOylation site mutagenesis (K339R), kinase activity assays, HSP27 phosphorylation, actin filament imaging, EC migration assays, dominant-negative MK2","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — site-directed mutagenesis with functional readouts, single lab, multiple orthogonal cellular assays","pmids":["21131586"],"is_preprint":false},{"year":2012,"finding":"MK2 regulates mGluR-LTD in the hippocampus; MK2/3 double-knockout mice show impaired mGluR-LTD and deficient endocytosis of GluA1 AMPA receptor subunits, with corresponding deficits in hippocampal-dependent spatial reversal learning.","method":"MK2/3 double-knockout mice, electrophysiological LTD recordings, GluA1 endocytosis assays, spatial reversal learning behavioral tests","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic knockout with electrophysiology and behavioral phenotyping, single lab","pmids":["25134715"],"is_preprint":false},{"year":2009,"finding":"MK2 is required for the self-renewal capacity of haematopoietic stem cells (HSCs); MK2-deficient mice have reduced HSC numbers and impaired competitive repopulation. This function requires MK2 interaction with the polycomb group (PcG) complex, as an Edr2-non-binding MK2 mutant fails to rescue the repopulation defect.","method":"MK2 knockout mice, competitive repopulation assays, MK2 mutant (Edr2-non-binding) rescue experiments, cell cycle analysis","journal":"The EMBO journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic knockout with rescue by wild-type vs. mutant MK2, competitive repopulation assay, single lab","pmids":["19369945"],"is_preprint":false},{"year":2019,"finding":"A long isoform of MK2 is constitutively translated from an alternative CUG translation initiation site in the 5' UTR of its mRNA, dependent on the RNA helicase eIF4A1. The short (canonical) isoform phosphorylates Hsp27 in vivo, supports cell migration, and stress-induced immediate early gene expression; the long isoform has distinct interaction partners and does not perform these functions.","method":"Alternative translation initiation mapping, eIF4A1 inhibition, isoform-specific expression, in vivo Hsp27 phosphorylation assays, migration assays, interaction profiling (MS)","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — biochemical translation mapping and functional isoform comparison with multiple orthogonal assays, single lab","pmids":["31167133"],"is_preprint":false},{"year":2010,"finding":"MK2 and MK3 are the kinases responsible for phosphorylation of TTP at S52/S178 in LPS-stimulated macrophages; these phosphorylations stabilize TTP protein but release ARE-containing mRNAs from translational repression and inhibit their nucleolytic degradation. MK2/3 also contribute to de novo synthesis of TTP.","method":"MK2 KO, MK3 KO, MK2/3 double KO macrophages, TTP phospho-site knock-in (TTPaa) mice, cytokine measurement, mRNA stability assays","journal":"Biochemical pharmacology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple genetic knockout and knock-in models, multiple cytokine readouts, replicated across labs","pmids":["20599781","31527197"],"is_preprint":false},{"year":2011,"finding":"BMP-2-induced cell migration requires activation of the p38/MK2/Hsp25 pathway downstream of BMP receptors; genetic ablation of either p38α or MK2 blocks downstream effector activation and BMP-2-induced cell migration. Phosphorylated Hsp25 colocalizes with BMP receptor complexes in lamellipodia; a phosphorylation-null Hsp25 mutant abolishes BMP-2-induced migration.","method":"p38α and MK2 genetic ablation (MEFs), kinase activity assays, immunofluorescence of phospho-Hsp25 localization, overexpression of phospho-null Hsp25, cell migration assays","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic ablation with phospho-null mutagenesis and localization studies, single lab","pmids":["21297993"],"is_preprint":false},{"year":2007,"finding":"MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase required for TGFβ-mediated MMP-2 activation and cell invasion in prostate cancer; dominant-negative MAPKAPK2 blocks HSP27 phosphorylation, and either dominant-negative MAPKAPK2 or non-phosphorylatable HSP27 blocks TGFβ-mediated MMP-2 activity and invasion.","method":"Transient transfection of wild-type, constitutively active, and dominant-negative MAPKAPK2; non-phosphorylatable HSP27 mutant; siRNA knockdown; MMP-2 activity assays; invasion assays","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — dominant-negative and siRNA approaches with functional readouts, single lab, multiple orthogonal methods","pmids":["16407830"],"is_preprint":false},{"year":2002,"finding":"The p38 MAPK/MAPKAPK2 signaling pathway regulates urokinase plasminogen activator (uPA) mRNA stability through AU-rich elements in its 3'-UTR in invasive breast cancer cells; the pathway is activated via Rac1-MKK3-p38-MAPKAPK2.","method":"Dominant-negative Rac1, constitutively active MKK3/MKK6 mutants, dominant-negative MKK3, beta-globin reporter with uPA 3'-UTR/ARE-deleted 3'-UTR, mRNA stability assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reporter assays with ARE deletion, epistasis with dominant negatives, single lab","pmids":["12377770"],"is_preprint":false},{"year":2012,"finding":"MK2 regulates TNF-α-induced ICAM-1 and IL-8 expression via phosphorylation of tristetraprolin (TTP) in human pulmonary microvascular endothelial cells; MK2 silencing reduces ICAM-1 and IL-8 mRNA half-lives and decreases TTP phosphorylation, while TTP silencing stabilizes these mRNAs.","method":"MK2 siRNA knockdown, TTP siRNA knockdown, mRNA stability assays (half-life measurement), TTP phosphorylation immunoblotting","journal":"American journal of physiology. Lung cellular and molecular physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA epistasis with mRNA stability readout, single lab, two orthogonal knockdown strategies","pmids":["22268119"],"is_preprint":false},{"year":2020,"finding":"MK2 promotes SRC-3 (steroid receptor coactivator-3) phosphorylation at Ser857 via the p38MAPK-MK2 axis; this phosphorylation drives nuclear translocation of SRC-3 and enhances NF-κB-mediated IL-6 transcription.","method":"p38MAPK-MK2 pathway inhibition, phospho-site analysis, nuclear translocation assays, NF-κB reporter assays, IL-6 transcription measurement","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pathway inhibition with phospho-site and nuclear localization readouts, single lab","pmids":["32647362"],"is_preprint":false},{"year":2018,"finding":"MK2 phosphorylates p47phox at Ser329, enhancing NADPH oxidase activation and superoxide production in neutrophils; MK2-deficient neutrophils show reduced p47phox phosphorylation and lower superoxide generation in response to C5a.","method":"MK2-/- mice, myeloid-specific MK2 KO (MK2Lyz2-KO), Ser329 phosphorylation site identification, superoxide production assays, NADPH oxidase activity measurement","journal":"Frontiers in immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic knockout with phospho-site identification, single lab with two KO models","pmids":["30483268"],"is_preprint":false},{"year":2021,"finding":"FIRINOX chemotherapy triggers autocrine TNFα signaling that activates TAK1→MK2→Hsp27 axis in PDAC; MK2 directly phosphorylates Hsp27 to confer chemoresistance. MK2 inhibition blocks Hsp27 activation, sensitizes PDAC to apoptosis, and suppresses protective autophagy in part by blocking Beclin1 phosphorylation.","method":"Reverse-phase protein array, siRNA knockdown, MK2 inhibitor (ATI-450), in vitro kinase assays, autochthonous PDAC mouse model, Beclin1 phosphorylation assays","journal":"Science translational medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — reverse-phase protein array plus mechanistic follow-up with kinase assays, validated in autochthonous mouse model with multiple orthogonal methods","pmids":["34851698"],"is_preprint":false},{"year":2022,"finding":"The p38/MK2 complex phosphorylates MFF1 (mitochondrial fission factor 1) at S155, leading to VDAC1 oligomerization and mitochondrial membrane pore formation through which HSP60 is released; cytosolic HSP60 then activates the IKK complex to induce NF-κB-dependent survival gene expression.","method":"MFF1 phosphorylation site mutagenesis, VDAC1 oligomerization assays, HSP60 release measurement, IKK complex co-IP, NF-κB reporter assays, mouse xenograft model","journal":"Redox biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — site mutagenesis with multiple mechanistic readouts, single lab","pmids":["35316673"],"is_preprint":false},{"year":2012,"finding":"The p38-MK2 axis directly phosphorylates E2F1 at Ser-364 in vitro and mediates epirubicin-induced E2F1 induction, which in turn drives FOXM1 expression. MK2 also limits JNK induction by epirubicin, and JNK represses FOXM1 expression.","method":"In vitro phosphorylation assay (MK2 phosphorylates E2F1 at Ser-364), siRNA knockdown, MK2-/- MEFs, pharmacological inhibitors, transfection with E2F1 Ser-364 mutants","journal":"Molecular cancer research : MCR","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — direct in vitro phosphorylation confirmed plus genetic KO and mutagenesis, single lab","pmids":["22802261"],"is_preprint":false},{"year":2007,"finding":"MK2 is required for TGFβ-induced myofibroblast differentiation (smooth muscle alpha-actin upregulation); in MK2-/- MEFs, TGFβ causes downregulation rather than upregulation of smooth muscle alpha-actin, associated with reduced smalpha mRNA stability rather than altered promoter activity.","method":"MK2 knockout MEFs, TGFβ stimulation, smalpha expression analysis, mRNA stability assays, serum-responsive promoter reporter assays","journal":"Journal of cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO with mRNA stability readout, single lab","pmids":["17163490"],"is_preprint":false},{"year":2014,"finding":"MK2 promotes M2 macrophage polarization and tumor angiogenesis; whole-animal and myeloid-specific MK2 KO demonstrates that MK2 activity in the myeloid compartment supports tumor neoangiogenesis and drives polarization of tumor-associated macrophages into protumorigenic, proangiogenic M2-like macrophages.","method":"Whole-animal and tissue-specific (myeloid) MK2 KO mice, tumor growth assays, macrophage polarization assays, angiogenesis assays, MK2 chemical inhibition in human cell lines","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — tissue-specific KO mice with cellular mechanistic follow-up, single lab","pmids":["29666270"],"is_preprint":false},{"year":2018,"finding":"Mesenchymal MK2 drives intestinal carcinogenesis through phosphorylation of Hsp27, which affects downstream tumorigenic effector molecules controlling epithelial proliferation, apoptosis, and angiogenesis; deletion of MK2 in intestinal mesenchymal cells reduces tumor multiplicity and growth in the Apcmin/+ model.","method":"Conditional (mesenchymal, epithelial, endothelial) MK2 KO mice, Apcmin/+ model, colitis-associated carcinogenesis model, Hsp27 phosphorylation analysis, tumor growth/invasion assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-type-specific conditional KO in two cancer models with mechanistic Hsp27 phosphorylation readout, multiple orthogonal lines of evidence","pmids":["29844172"],"is_preprint":false},{"year":2005,"finding":"p38α is required for MAPKAPK2 (MK2) protein expression; in p38α-null fibroblasts and embryonic extracts, MK2 expression is greatly reduced and is restored by re-introduction of p38α.","method":"p38α knockout cell lines, embryonic extracts from p38α-null mice, p38α re-introduction rescue, immunoblotting for MK2","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO with rescue in multiple models, single lab","pmids":["16198317"],"is_preprint":false},{"year":2014,"finding":"In HPV-positive cells, p38 and MK2 are phosphorylated and relocalize to the cytoplasm; pharmacological inhibition of MK2 or p38 blocks HPV genome amplification, identifying the p38/MK2 pathway as a key regulator of the HPV differentiation-dependent life cycle.","method":"MK2 and p38 inhibitor treatment, HPV genome amplification assays, subcellular localization analysis","journal":"Journal of virology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — pharmacological inhibition only, no direct substrate identification, single lab","pmids":["25410865"],"is_preprint":false}],"current_model":"MAPKAPK2 (MK2) is a stress-activated serine/threonine kinase that functions directly downstream of p38 MAPKα/β, which bind to a C-terminal docking motif and phosphorylate MK2's regulatory sites; upon activation, MK2 translocates from nucleus to cytoplasm (co-exporting p38) and phosphorylates a broad substrate spectrum including: TTP/ZFP36L1 (inhibiting mRNA degradation and releasing ARE-containing mRNAs including TNF for translation), Hsp27/Hsp25 (remodeling actin cytoskeleton and modulating stress granule formation), RIPK1 at S321 (suppressing TNF-induced apoptosis and necroptosis), Beclin 1 at S90 (promoting autophagy), CEP131 at S47/S78 (triggering 14-3-3-dependent centriolar satellite remodelling), NELFE at S115 (causing NELF complex dissociation from chromatin and RNA Pol II elongation), keratins K18-S52 and K20-S13, LSP1 at S243 (stabilizing F-actin polarization in neutrophils), PDE4A5 at S147 (attenuating cAMP desensitization), and E2F1 at S364; MK2 additionally stabilizes p38 protein levels through its C-terminus independent of kinase activity and requires its proline-rich N-terminal region for cell migration but its catalytic activity for cytokine production."},"narrative":{"mechanistic_narrative":"MAPKAPK2 (MK2) is a stress-activated serine/threonine kinase that operates as the principal downstream effector of p38 MAPK, integrating inflammatory, genotoxic, and mechanical stress signals into control of mRNA stability, cytoskeletal dynamics, cell death, and autophagy [PMID:12052889, PMID:23028373]. p38 MAPKα/β bind a basic docking motif in the MK2 C-terminus and phosphorylate its regulatory sites, triggering nuclear export of MK2 together with active p38; MK2 also stabilizes p38 protein levels through a C-terminal interaction that is independent of its catalytic activity, while p38α reciprocally is required for MK2 protein expression [PMID:12052889, PMID:16198317]. A central MK2 output is post-transcriptional control of inflammatory gene expression: MK2 phosphorylates the ARE-binding proteins tristetraprolin (TTP/ZFP36) at S52/S178 and ZFP36L1, lowering their affinity for AU-rich elements, releasing ARE-containing transcripts such as TNF, ICAM-1, IL-8, and SASP factors from repression and degradation, and permitting HuR-mediated translation [PMID:23028373, PMID:20599781, PMID:31527197, PMID:26280535, PMID:22268119]. Through phosphorylation of the small heat-shock protein Hsp27/Hsp25 at S86, MK2 remodels the actin cytoskeleton and modulates stress resistance, driving cell migration downstream of BMP-2 and TGFβ and promoting invasion and chemoresistance in cancer [PMID:16840785, PMID:21297993, PMID:16407830, PMID:34851698]. MK2 directly phosphorylates a broad substrate spectrum that diversifies its biology: RIPK1 at S321 to suppress TNF-induced apoptosis and necroptosis [PMID:28506461, PMID:28920954, PMID:28920952], Beclin 1 at S90 to promote starvation-induced autophagy [PMID:25693418], CEP131 at S47/S78 and NELFE at S115 to create 14-3-3 docking sites controlling centriolar satellite remodelling and RNA Pol II elongation after UV stress [PMID:26616734, PMID:29523821], PDE4A5 at S147 to amplify cAMP signalling [PMID:21323643], and epithelial keratins K18-S52 and K20-S13 to regulate mucin secretion [PMID:20724476]. Distinct structural regions and modifications partition these functions — the catalytic activity drives cytokine production while a proline-rich N-terminal region is required for migration, and SUMOylation at K339 dampens kinase output [PMID:12052889, PMID:21131586]. In vivo, MK2 governs zebrafish epiboly via F-actin at the yolk margin, hematopoietic stem cell self-renewal through a polycomb interaction, hippocampal mGluR-LTD, and tumor-promoting macrophage polarization and stromal signalling [PMID:19282986, PMID:19369945, PMID:25134715, PMID:29666270, PMID:29844172].","teleology":[{"year":2002,"claim":"Established how MK2 is activated and how its modular architecture partitions distinct outputs, defining MK2 as a p38-controlled effector with separable functions for cytokine production versus migration.","evidence":"MK2 knockout macrophages and MEFs with reconstitution of MK2 isoforms/mutants, p38 protein measurement, TNF and migration assays","pmids":["12052889"],"confidence":"High","gaps":["Did not enumerate the full substrate set downstream of activation","Structural basis of the C-terminal docking and p38 stabilization not resolved here"]},{"year":2005,"claim":"Showed the MK2–p38 relationship is mutually stabilizing at the protein level, with p38α required for MK2 expression, framing the pair as an interdependent module.","evidence":"p38α-null fibroblasts and embryonic extracts with p38α re-introduction rescue, MK2 immunoblotting","pmids":["16198317"],"confidence":"Medium","gaps":["Mechanism of reciprocal stabilization at molecular level not defined","Single lab"]},{"year":2007,"claim":"Resolved the MK2 kinase domain and its ATP/inhibitor-binding site, providing a structural basis for selective inhibition and linking inhibition to suppression of TNF-α.","evidence":"X-ray crystallography of MK2-inhibitor complexes in two crystal forms, in vitro kinase and cellular TNF-α assays","pmids":["17449059","17480064"],"confidence":"High","gaps":["No structure of MK2 bound to a physiological substrate","Conformational states during activation not captured"]},{"year":2006,"claim":"Demonstrated that MK2 phosphorylation of Hsp25/Hsp27 controls oligomer disaggregation, 14-3-3 binding, and stress resistance, establishing the central cytoskeletal/chaperone branch of MK2 signalling.","evidence":"MK2 knockout fibroblasts, in vitro phosphorylation, 14-3-3 binding, GFP-Hsp25 imaging and solubility fractionation under multiple stresses","pmids":["16840785"],"confidence":"High","gaps":["Downstream actin-remodeling effectors not fully mapped","Relationship between Hsp25 phosphorylation and cell-fate decisions partly correlative"]},{"year":2012,"claim":"Defined the molecular logic of MK2-driven mRNA stabilization by showing MK2 phosphorylation of TTP triggers a TTP-to-HuR exchange that switches transcripts from unstable/untranslated to stable/translated.","evidence":"ARE reporter assays, TTP/HuR binding and phospho-site mutagenesis in MK2 knockout macrophages","pmids":["23028373"],"confidence":"High","gaps":["In vivo physiological scope of the exchange beyond TNF not fully delineated here"]},{"year":2010,"claim":"Genetic knockout/knock-in models identified MK2 and MK3 as the kinases phosphorylating TTP at S52/S178 in vivo, anchoring MK2's role in post-transcriptional control of inflammation.","evidence":"MK2 KO, MK3 KO, MK2/3 double-KO macrophages and TTP phospho-site knock-in mice with cytokine and mRNA stability readouts","pmids":["20599781","31527197"],"confidence":"High","gaps":["Relative contribution of MK2 versus MK3 across cell types not fully resolved"]},{"year":2015,"claim":"Expanded the substrate spectrum into autophagy and stress-response chromatin/organelle control, showing MK2 phosphorylates Beclin 1 (S90), CEP131 (S47/S78), and ZFP36L1 to govern autophagy, centriolar satellites, and SASP.","evidence":"In vitro kinase assays, phospho-site mutagenesis, 14-3-3 binding, autophagy flux, live-cell imaging, and senescence/SASP assays","pmids":["25693418","26616734","26280535"],"confidence":"High","gaps":["Coordination among these parallel substrate branches in a single cell unclear","Upstream stimulus selectivity for each substrate not defined"]},{"year":2017,"claim":"Established MK2 as a direct brake on cell death by phosphorylating RIPK1 at S321 to block its kinase activation and FADD/caspase-8 engagement, suppressing apoptosis and necroptosis.","evidence":"In vitro kinase assay, S321D phospho-mimetic mutagenesis, Co-IP, and cell death assays, replicated across three labs","pmids":["28506461","28920954","28920952"],"confidence":"High","gaps":["Integration with the cytokine-producing arm of MK2 in the same TNF response not fully reconciled"]},{"year":2018,"claim":"Showed MK2 couples DNA-damage stress to transcription by phosphorylating NELFE (S115) to evict the NELF complex and license RNA Pol II elongation via 14-3-3 recruitment.","evidence":"Quantitative phosphoproteomics, in vitro phosphorylation, 14-3-3 binding, chromatin fractionation, and Pol II elongation assays","pmids":["29523821"],"confidence":"High","gaps":["Genome-wide set of MK2-dependent elongation targets not defined","Single comprehensive study"]},{"year":2021,"claim":"Demonstrated therapeutic relevance of the MK2–Hsp27 axis, showing chemotherapy-induced TNFα drives TAK1→MK2→Hsp27 signalling and protective autophagy to confer chemoresistance in pancreatic cancer.","evidence":"Reverse-phase protein array, siRNA, MK2 inhibitor ATI-450, in vitro kinase and Beclin1 phosphorylation assays in an autochthonous PDAC mouse model","pmids":["34851698"],"confidence":"High","gaps":["Relative contribution of Hsp27 versus Beclin1 branches to resistance not separated","Durability of MK2 inhibition not addressed"]},{"year":null,"claim":"How MK2 selects among its many substrates in a given stress context, and how isoform, SUMOylation, and subcellular partitioning route signal flow, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model of substrate prioritization under combined stresses","Regulatory role of the long CUG-initiated MK2 isoform incompletely mapped","Structural basis of substrate docking not determined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[1,3,4,8,9,10,11]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[1,3,4,9,10,11]},{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[6,7]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[2,10]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[2,9]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[2,3,19,23]},{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[0,3,19,22]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[1,26]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[4,26]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[9,10,13]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[10,28]}],"complexes":[],"partners":["MAPK14","HSPB1","ZFP36","RIPK1","BECN1","CEP131","NELFE","PDE4A5"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P49137","full_name":"MAP kinase-activated protein kinase 2","aliases":[],"length_aa":400,"mass_kda":45.6,"function":"Stress-activated serine/threonine-protein kinase involved in cytokine production, endocytosis, reorganization of the cytoskeleton, cell migration, cell cycle control, chromatin remodeling, DNA damage response and transcriptional regulation. Following stress, it is phosphorylated and activated by MAP kinase p38-alpha/MAPK14, leading to phosphorylation of substrates. Phosphorylates serine in the peptide sequence, Hyd-X-R-X(2)-S, where Hyd is a large hydrophobic residue. Phosphorylates ALOX5, CDC25B, CDC25C, CEP131, ELAVL1, HNRNPA0, HSP27/HSPB1, KRT18, KRT20, LIMK1, LSP1, PABPC1, PARN, PDE4A, RCSD1, RPS6KA3, TAB3 and TTP/ZFP36. Phosphorylates HSF1; leading to the interaction with HSP90 proteins and inhibiting HSF1 homotrimerization, DNA-binding and transactivation activities (PubMed:16278218). Mediates phosphorylation of HSP27/HSPB1 in response to stress, leading to the dissociation of HSP27/HSPB1 from large small heat-shock protein (sHsps) oligomers and impairment of their chaperone activities and ability to protect against oxidative stress effectively. Involved in inflammatory response by regulating tumor necrosis factor (TNF) and IL6 production post-transcriptionally: acts by phosphorylating AU-rich elements (AREs)-binding proteins ELAVL1, HNRNPA0, PABPC1 and TTP/ZFP36, leading to the regulation of the stability and translation of TNF and IL6 mRNAs. Phosphorylation of TTP/ZFP36, a major post-transcriptional regulator of TNF, promotes its binding to 14-3-3 proteins and reduces its ARE mRNA affinity, leading to inhibition of dependent degradation of ARE-containing transcripts. Phosphorylates CEP131 in response to cellular stress induced by ultraviolet irradiation which promotes binding of CEP131 to 14-3-3 proteins and inhibits formation of novel centriolar satellites (PubMed:26616734). Also involved in late G2/M checkpoint following DNA damage through a process of post-transcriptional mRNA stabilization: following DNA damage, relocalizes from nucleus to cytoplasm and phosphorylates HNRNPA0 and PARN, leading to stabilization of GADD45A mRNA. Involved in toll-like receptor signaling pathway (TLR) in dendritic cells: required for acute TLR-induced macropinocytosis by phosphorylating and activating RPS6KA3","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/P49137/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/MAPKAPK2","classification":"Not Classified","n_dependent_lines":6,"n_total_lines":1208,"dependency_fraction":0.004966887417218543},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000162889","cell_line_id":"CID001209","localizations":[{"compartment":"cytoplasmic","grade":3},{"compartment":"nucleoplasm","grade":3},{"compartment":"centrosome","grade":2}],"interactors":[{"gene":"MAPK14","stoichiometry":10.0},{"gene":"MAPK11","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID001209","total_profiled":1310},"omim":[{"mim_id":"616175","title":"UBIQUITIN-CONJUGATING ENZYME E2 J1; UBE2J1","url":"https://www.omim.org/entry/616175"},{"mim_id":"610579","title":"RCSD DOMAIN-CONTAINING PROTEIN 1; RCSD1","url":"https://www.omim.org/entry/610579"},{"mim_id":"609827","title":"PELLINO E3 UBIQUITIN PROTEIN LIGASE 3; PELI3","url":"https://www.omim.org/entry/609827"},{"mim_id":"606724","title":"MITOGEN-ACTIVATED PROTEIN KINASE-INTERACTING SERINE/THREONINE KINASE 1; MKNK1","url":"https://www.omim.org/entry/606724"},{"mim_id":"606723","title":"MITOGEN-ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE 5; MAPKAPK5","url":"https://www.omim.org/entry/606723"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Centrosome","reliability":"Additional"},{"location":"Basal body","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/MAPKAPK2"},"hgnc":{"alias_symbol":["MK2"],"prev_symbol":[]},"alphafold":{"accession":"P49137","domains":[{"cath_id":"3.30.200.20","chopping":"60-140","consensus_level":"high","plddt":94.1854,"start":60,"end":140},{"cath_id":"1.10.510.10","chopping":"145-216_235-364","consensus_level":"high","plddt":88.3856,"start":145,"end":364}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P49137","model_url":"https://alphafold.ebi.ac.uk/files/AF-P49137-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P49137-F1-predicted_aligned_error_v6.png","plddt_mean":82.56},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MAPKAPK2","jax_strain_url":"https://www.jax.org/strain/search?query=MAPKAPK2"},"sequence":{"accession":"P49137","fasta_url":"https://rest.uniprot.org/uniprotkb/P49137.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P49137/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P49137"}},"corpus_meta":[{"pmid":"26280535","id":"PMC_26280535","title":"mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype.","date":"2015","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/26280535","citation_count":615,"is_preprint":false},{"pmid":"19230643","id":"PMC_19230643","title":"Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2.","date":"2009","source":"Current opinion in cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/19230643","citation_count":405,"is_preprint":false},{"pmid":"28506461","id":"PMC_28506461","title":"MK2 Phosphorylates RIPK1 to Prevent TNF-Induced Cell Death.","date":"2017","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/28506461","citation_count":266,"is_preprint":false},{"pmid":"12052889","id":"PMC_12052889","title":"Distinct cellular functions of MK2.","date":"2002","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12052889","citation_count":205,"is_preprint":false},{"pmid":"28920954","id":"PMC_28920954","title":"p38MAPK/MK2-dependent phosphorylation controls cytotoxic RIPK1 signalling in inflammation and infection.","date":"2017","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/28920954","citation_count":198,"is_preprint":false},{"pmid":"20068172","id":"PMC_20068172","title":"p38 mitogen-activated protein kinase-driven MAPKAPK2 regulates invasion of bladder cancer by modulation of MMP-2 and MMP-9 activity.","date":"2010","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/20068172","citation_count":190,"is_preprint":false},{"pmid":"23028373","id":"PMC_23028373","title":"The p38/MK2-driven exchange between tristetraprolin and HuR regulates AU-rich element-dependent translation.","date":"2012","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23028373","citation_count":188,"is_preprint":false},{"pmid":"28920952","id":"PMC_28920952","title":"MK2 phosphorylation of RIPK1 regulates TNF-mediated cell death.","date":"2017","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/28920952","citation_count":176,"is_preprint":false},{"pmid":"16407830","id":"PMC_16407830","title":"MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase-mediated matrix metalloproteinase type 2 activation and cell invasion in human prostate cancer.","date":"2006","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/16407830","citation_count":171,"is_preprint":false},{"pmid":"25693418","id":"PMC_25693418","title":"The stress-responsive kinases MAPKAPK2/MAPKAPK3 activate starvation-induced autophagy through Beclin 1 phosphorylation.","date":"2015","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/25693418","citation_count":157,"is_preprint":false},{"pmid":"20212154","id":"PMC_20212154","title":"p38 MAPK/MK2-mediated induction of miR-34c following DNA damage prevents Myc-dependent DNA replication.","date":"2010","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/20212154","citation_count":148,"is_preprint":false},{"pmid":"10666409","id":"PMC_10666409","title":"Ischemic preconditioning activates MAPKAPK2 in the isolated rabbit heart: evidence for involvement of p38 MAPK.","date":"2000","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/10666409","citation_count":145,"is_preprint":false},{"pmid":"17480064","id":"PMC_17480064","title":"Pyrrolopyridine inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2).","date":"2007","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17480064","citation_count":140,"is_preprint":false},{"pmid":"29452637","id":"PMC_29452637","title":"Ubiquitin-Mediated Regulation of RIPK1 Kinase Activity Independent of IKK and MK2.","date":"2018","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/29452637","citation_count":121,"is_preprint":false},{"pmid":"26140595","id":"PMC_26140595","title":"A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant Cancer.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26140595","citation_count":106,"is_preprint":false},{"pmid":"24423080","id":"PMC_24423080","title":"A p38MAPK/MK2 signaling pathway leading to redox stress, cell death and ischemia/reperfusion injury.","date":"2014","source":"Cell communication and signaling : CCS","url":"https://pubmed.ncbi.nlm.nih.gov/24423080","citation_count":104,"is_preprint":false},{"pmid":"30850014","id":"PMC_30850014","title":"MAPKAPK2: the master regulator of RNA-binding proteins modulates transcript stability and tumor progression.","date":"2019","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/30850014","citation_count":95,"is_preprint":false},{"pmid":"20599781","id":"PMC_20599781","title":"MAPKAP kinases MK2 and MK3 in inflammation: complex regulation of TNF biosynthesis via expression and phosphorylation of tristetraprolin.","date":"2010","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/20599781","citation_count":87,"is_preprint":false},{"pmid":"29666270","id":"PMC_29666270","title":"MK2 contributes to tumor progression by promoting M2 macrophage polarization and tumor angiogenesis.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/29666270","citation_count":87,"is_preprint":false},{"pmid":"29549113","id":"PMC_29549113","title":"Selective inhibition of the p38α MAPK-MK2 axis inhibits inflammatory cues including inflammasome priming signals.","date":"2018","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29549113","citation_count":82,"is_preprint":false},{"pmid":"23185379","id":"PMC_23185379","title":"Survival of cancer stem cells under hypoxia and serum depletion via decrease in PP2A activity and activation of p38-MAPKAPK2-Hsp27.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23185379","citation_count":80,"is_preprint":false},{"pmid":"17163490","id":"PMC_17163490","title":"Smooth muscle alpha-actin expression and myofibroblast differentiation by TGFbeta are dependent upon MK2.","date":"2007","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17163490","citation_count":80,"is_preprint":false},{"pmid":"26859455","id":"PMC_26859455","title":"Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-Mimetics.","date":"2016","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/26859455","citation_count":79,"is_preprint":false},{"pmid":"12377770","id":"PMC_12377770","title":"Rac1-MKK3-p38-MAPKAPK2 pathway promotes urokinase plasminogen activator mRNA stability in invasive breast cancer cells.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12377770","citation_count":74,"is_preprint":false},{"pmid":"26901653","id":"PMC_26901653","title":"SB203580 Modulates p38 MAPK Signaling and Dengue Virus-Induced Liver Injury by Reducing MAPKAPK2, HSP27, and ATF2 Phosphorylation.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26901653","citation_count":72,"is_preprint":false},{"pmid":"29197088","id":"PMC_29197088","title":"Inhibition of MK2 suppresses IL-1β, IL-6, and TNF-α-dependent colorectal cancer growth.","date":"2017","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/29197088","citation_count":69,"is_preprint":false},{"pmid":"29523821","id":"PMC_29523821","title":"p38-MK2 signaling axis regulates RNA metabolism after UV-light-induced DNA damage.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29523821","citation_count":68,"is_preprint":false},{"pmid":"18620516","id":"PMC_18620516","title":"MK2: a novel molecular target for anti-inflammatory therapy.","date":"2008","source":"Expert opinion on therapeutic targets","url":"https://pubmed.ncbi.nlm.nih.gov/18620516","citation_count":67,"is_preprint":false},{"pmid":"18508601","id":"PMC_18508601","title":"MK2 and MK3--a pair of isoenzymes?","date":"2008","source":"Frontiers in bioscience : a journal and virtual library","url":"https://pubmed.ncbi.nlm.nih.gov/18508601","citation_count":63,"is_preprint":false},{"pmid":"26502061","id":"PMC_26502061","title":"Targeting Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MAPKAPK2, MK2): Medicinal Chemistry Efforts To Lead Small Molecule Inhibitors to Clinical Trials.","date":"2015","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26502061","citation_count":62,"is_preprint":false},{"pmid":"25088200","id":"PMC_25088200","title":"The p38-MK2-HuR pathway potentiates EGFRvIII-IL-1β-driven IL-6 secretion in glioblastoma cells.","date":"2014","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/25088200","citation_count":62,"is_preprint":false},{"pmid":"25134715","id":"PMC_25134715","title":"The MK2/3 cascade regulates AMPAR trafficking and cognitive flexibility.","date":"2014","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/25134715","citation_count":59,"is_preprint":false},{"pmid":"20227494","id":"PMC_20227494","title":"Mitogen-activated protein kinase p38 and MK2, MK3 and MK5: ménage à trois or ménage à quatre?","date":"2010","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/20227494","citation_count":58,"is_preprint":false},{"pmid":"30093561","id":"PMC_30093561","title":"Inhibition of the Stromal p38MAPK/MK2 Pathway Limits Breast Cancer Metastases and Chemotherapy-Induced Bone Loss.","date":"2018","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/30093561","citation_count":54,"is_preprint":false},{"pmid":"29207040","id":"PMC_29207040","title":"Aryl hydrocarbon receptor inhibits inflammation in DSS‑induced colitis via the MK2/p‑MK2/TTP pathway.","date":"2017","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29207040","citation_count":53,"is_preprint":false},{"pmid":"22802261","id":"PMC_22802261","title":"The p38 MAPK-MK2 axis regulates E2F1 and FOXM1 expression after epirubicin treatment.","date":"2012","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/22802261","citation_count":51,"is_preprint":false},{"pmid":"21323643","id":"PMC_21323643","title":"Phosphorylation of cAMP-specific PDE4A5 (phosphodiesterase-4A5) by MK2 (MAPKAPK2) attenuates its activation through protein kinase A phosphorylation.","date":"2011","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/21323643","citation_count":50,"is_preprint":false},{"pmid":"33585492","id":"PMC_33585492","title":"The p38MAPK-MK2 Signaling Axis as a Critical Link Between Inflammation and Synaptic Transmission.","date":"2021","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/33585492","citation_count":50,"is_preprint":false},{"pmid":"27694493","id":"PMC_27694493","title":"MK2/3 Are Pivotal for IL-33-Induced and Mast Cell-Dependent Leukocyte Recruitment and the Resulting Skin Inflammation.","date":"2016","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/27694493","citation_count":50,"is_preprint":false},{"pmid":"20943915","id":"PMC_20943915","title":"Mitogen-activated protein kinase-activated protein kinase 2 (MK2) contributes to secondary damage after spinal cord injury.","date":"2010","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/20943915","citation_count":49,"is_preprint":false},{"pmid":"23657501","id":"PMC_23657501","title":"MAPKAP kinase 2 (MK2)-dependent and -independent models of blister formation in pemphigus vulgaris.","date":"2013","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/23657501","citation_count":48,"is_preprint":false},{"pmid":"19282986","id":"PMC_19282986","title":"A novel role for MAPKAPK2 in morphogenesis during zebrafish development.","date":"2009","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19282986","citation_count":48,"is_preprint":false},{"pmid":"19609314","id":"PMC_19609314","title":"MAPKAPK-2 signaling is critical for cutaneous wound healing.","date":"2010","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/19609314","citation_count":47,"is_preprint":false},{"pmid":"26616734","id":"PMC_26616734","title":"p38- and MK2-dependent signalling promotes stress-induced centriolar satellite remodelling via 14-3-3-dependent sequestration of CEP131/AZI1.","date":"2015","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/26616734","citation_count":46,"is_preprint":false},{"pmid":"19171422","id":"PMC_19171422","title":"SAGE analysis highlights the importance of p53csv, ddx5, mapkapk2 and ranbp2 to multiple myeloma tumorigenesis.","date":"2009","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/19171422","citation_count":44,"is_preprint":false},{"pmid":"30171775","id":"PMC_30171775","title":"IL-33 regulates cytokine production and neutrophil recruitment via the p38 MAPK-activated kinases MK2/3.","date":"2018","source":"Immunology and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/30171775","citation_count":44,"is_preprint":false},{"pmid":"28582691","id":"PMC_28582691","title":"Biological functions and role of mitogen-activated protein kinase activated protein kinase 2 (MK2) in inflammatory diseases.","date":"2017","source":"Pharmacological reports : PR","url":"https://pubmed.ncbi.nlm.nih.gov/28582691","citation_count":43,"is_preprint":false},{"pmid":"26062847","id":"PMC_26062847","title":"MK2 inhibitory peptide delivered in nanopolyplexes prevents vascular graft intimal hyperplasia.","date":"2015","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26062847","citation_count":43,"is_preprint":false},{"pmid":"34302158","id":"PMC_34302158","title":"Rutin prevents inflammation-associated colon damage via inhibiting the p38/MAPKAPK2 and PI3K/Akt/GSK3β/NF-κB signalling axes and enhancing splenic Tregs in DSS-induced murine chronic colitis.","date":"2021","source":"Food & function","url":"https://pubmed.ncbi.nlm.nih.gov/34302158","citation_count":42,"is_preprint":false},{"pmid":"18469532","id":"PMC_18469532","title":"DNA damage-induced S phase arrest in human breast cancer depends on Chk1, but G2 arrest can occur independently of Chk1, Chk2 or MAPKAPK2.","date":"2008","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/18469532","citation_count":42,"is_preprint":false},{"pmid":"21131586","id":"PMC_21131586","title":"MK2 SUMOylation regulates actin filament remodeling and subsequent migration in endothelial cells by inhibiting MK2 kinase and HSP27 phosphorylation.","date":"2010","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/21131586","citation_count":42,"is_preprint":false},{"pmid":"29275999","id":"PMC_29275999","title":"MK2-TNF-Signaling Comes Full Circle.","date":"2017","source":"Trends in biochemical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29275999","citation_count":41,"is_preprint":false},{"pmid":"31804564","id":"PMC_31804564","title":"Resveratrol inhibits IL-33-mediated mast cell activation by targeting the MK2/3-PI3K/Akt axis.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31804564","citation_count":41,"is_preprint":false},{"pmid":"15623425","id":"PMC_15623425","title":"MK2-/- gene knockout mouse hearts carry anti-apoptotic signal and are resistant to ischemia reperfusion injury.","date":"2004","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/15623425","citation_count":41,"is_preprint":false},{"pmid":"32596245","id":"PMC_32596245","title":"MK2 Is Required for Neutrophil-Derived ROS Production and Inflammatory Bowel Disease.","date":"2020","source":"Frontiers in medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32596245","citation_count":39,"is_preprint":false},{"pmid":"18562219","id":"PMC_18562219","title":"Mitogen-activated protein kinase-activated protein kinase 2 (MK2) modulates key biological pathways associated with OA disease pathology.","date":"2008","source":"Osteoarthritis and cartilage","url":"https://pubmed.ncbi.nlm.nih.gov/18562219","citation_count":39,"is_preprint":false},{"pmid":"16423921","id":"PMC_16423921","title":"Gene deletion of MK2 inhibits TNF-alpha and IL-6 and protects against cerulein-induced pancreatitis.","date":"2006","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16423921","citation_count":39,"is_preprint":false},{"pmid":"26238259","id":"PMC_26238259","title":"Blockade of MK2 is protective in inflammation-associated colorectal cancer development.","date":"2015","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/26238259","citation_count":37,"is_preprint":false},{"pmid":"29844172","id":"PMC_29844172","title":"Mesenchymal MAPKAPK2/HSP27 drives intestinal carcinogenesis.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/29844172","citation_count":36,"is_preprint":false},{"pmid":"21297993","id":"PMC_21297993","title":"The p38/MK2/Hsp25 pathway is required for BMP-2-induced cell migration.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21297993","citation_count":36,"is_preprint":false},{"pmid":"16840785","id":"PMC_16840785","title":"Analysis of properties of small heat shock protein Hsp25 in MAPK-activated protein kinase 2 (MK2)-deficient cells: MK2-dependent insolubilization of Hsp25 oligomers correlates with susceptibility to stress.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16840785","citation_count":36,"is_preprint":false},{"pmid":"31575657","id":"PMC_31575657","title":"Sophoridine Inhibits Human Colorectal Cancer Progression via Targeting MAPKAPK2.","date":"2019","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/31575657","citation_count":35,"is_preprint":false},{"pmid":"30483268","id":"PMC_30483268","title":"A Role for MK2 in Enhancing Neutrophil-Derived ROS Production and Aggravating Liver Ischemia/Reperfusion Injury.","date":"2018","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30483268","citation_count":35,"is_preprint":false},{"pmid":"16198317","id":"PMC_16198317","title":"p38 mitogen-activated protein kinase plays a key role in regulating MAPKAPK2 expression.","date":"2005","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/16198317","citation_count":33,"is_preprint":false},{"pmid":"31527197","id":"PMC_31527197","title":"The Role of TTP Phosphorylation in the Regulation of Inflammatory Cytokine Production by MK2/3.","date":"2019","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/31527197","citation_count":33,"is_preprint":false},{"pmid":"30298062","id":"PMC_30298062","title":"MK2 Regulates Macrophage Chemokine Activity and Recruitment to Promote Colon Tumor Growth.","date":"2018","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30298062","citation_count":32,"is_preprint":false},{"pmid":"19808857","id":"PMC_19808857","title":"MK2 regulates the early stages of skin tumor promotion.","date":"2009","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/19808857","citation_count":31,"is_preprint":false},{"pmid":"17449059","id":"PMC_17449059","title":"Structural basis for a high affinity inhibitor bound to protein kinase MK2.","date":"2007","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17449059","citation_count":31,"is_preprint":false},{"pmid":"27619201","id":"PMC_27619201","title":"Treatment with MAPKAP2 (MK2) inhibitor and DNA methylation inhibitor, 5-aza dC, synergistically triggers apoptosis in hepatocellular carcinoma (HCC) via tristetraprolin (TTP).","date":"2016","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/27619201","citation_count":30,"is_preprint":false},{"pmid":"29770701","id":"PMC_29770701","title":"MK2 mediates macrophage activation and acute lung injury by regulating let-7e miRNA.","date":"2018","source":"American journal of physiology. Lung cellular and molecular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/29770701","citation_count":29,"is_preprint":false},{"pmid":"20724476","id":"PMC_20724476","title":"p38 MAP kinase and MAPKAP kinases MK2/3 cooperatively phosphorylate epithelial keratins.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20724476","citation_count":29,"is_preprint":false},{"pmid":"34559922","id":"PMC_34559922","title":"Mitogen-activated protein kinase-activated protein kinase-2 (MK2) and its role in cell survival, inflammatory signaling, and migration in promoting cancer.","date":"2021","source":"Molecular carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/34559922","citation_count":29,"is_preprint":false},{"pmid":"21426101","id":"PMC_21426101","title":"Low-molecular-weight MK2 inhibitors: a tough nut to crack!","date":"2009","source":"Future medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21426101","citation_count":29,"is_preprint":false},{"pmid":"26068544","id":"PMC_26068544","title":"Treatment of Obese Insulin-Resistant Mice With an Allosteric MAPKAPK2/3 Inhibitor Lowers Blood Glucose and Improves Insulin Sensitivity.","date":"2015","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/26068544","citation_count":28,"is_preprint":false},{"pmid":"27329698","id":"PMC_27329698","title":"MK2 inhibitor reduces alkali burn-induced inflammation in rat cornea.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27329698","citation_count":28,"is_preprint":false},{"pmid":"17481585","id":"PMC_17481585","title":"MAPKAPK2-mediated LSP1 phosphorylation and FMLP-induced neutrophil polarization.","date":"2007","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/17481585","citation_count":27,"is_preprint":false},{"pmid":"35691544","id":"PMC_35691544","title":"Discovery of CC-99677, a selective targeted covalent MAPKAPK2 (MK2) inhibitor for autoimmune disorders.","date":"2022","source":"Translational research : the journal of laboratory and clinical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35691544","citation_count":27,"is_preprint":false},{"pmid":"26558681","id":"PMC_26558681","title":"MK2 Deletion in Mice Prevents Diabetes-Induced Perturbations in Lipid Metabolism and Cardiac Dysfunction.","date":"2015","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/26558681","citation_count":27,"is_preprint":false},{"pmid":"31417185","id":"PMC_31417185","title":"MAPKAPK2 (MK2) inhibition mediates radiation-induced inflammatory cytokine production and tumor growth in head and neck squamous cell carcinoma.","date":"2019","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/31417185","citation_count":26,"is_preprint":false},{"pmid":"31129151","id":"PMC_31129151","title":"The MK2 cascade regulates mGluR-dependent synaptic plasticity and reversal learning.","date":"2019","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/31129151","citation_count":26,"is_preprint":false},{"pmid":"31167133","id":"PMC_31167133","title":"Alternative Translation Initiation Generates a Functionally Distinct Isoform of the Stress-Activated Protein Kinase MK2.","date":"2019","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/31167133","citation_count":26,"is_preprint":false},{"pmid":"31070456","id":"PMC_31070456","title":"Proinflammatory Effect of Endothelial Microparticles Is Mitochondria Mediated and Modulated Through MAPKAPK2 (MAPK-Activated Protein Kinase 2) Leading to Attenuation of Cardiac Hypertrophy.","date":"2019","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/31070456","citation_count":25,"is_preprint":false},{"pmid":"28900160","id":"PMC_28900160","title":"Induction of oxidative metabolism by the p38α/MK2 pathway.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28900160","citation_count":25,"is_preprint":false},{"pmid":"35982464","id":"PMC_35982464","title":"CC-99677, a novel, oral, selective covalent MK2 inhibitor, sustainably reduces pro-inflammatory cytokine production.","date":"2022","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/35982464","citation_count":25,"is_preprint":false},{"pmid":"34851698","id":"PMC_34851698","title":"The MK2/Hsp27 axis is a major survival mechanism for pancreatic ductal adenocarcinoma under genotoxic stress.","date":"2021","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34851698","citation_count":25,"is_preprint":false},{"pmid":"34622803","id":"PMC_34622803","title":"Therapeutic MK2 inhibition blocks pathological vascular smooth muscle cell phenotype switch.","date":"2021","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/34622803","citation_count":24,"is_preprint":false},{"pmid":"19369945","id":"PMC_19369945","title":"MAPKAP kinase MK2 maintains self-renewal capacity of haematopoietic stem cells.","date":"2009","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/19369945","citation_count":24,"is_preprint":false},{"pmid":"22268119","id":"PMC_22268119","title":"MK2 posttranscriptionally regulates TNF-α-induced expression of ICAM-1 and IL-8 via tristetraprolin in human pulmonary microvascular endothelial cells.","date":"2012","source":"American journal of physiology. Lung cellular and molecular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/22268119","citation_count":24,"is_preprint":false},{"pmid":"31023373","id":"PMC_31023373","title":"MAPKAPK2 plays a crucial role in the progression of head and neck squamous cell carcinoma by regulating transcript stability.","date":"2019","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/31023373","citation_count":22,"is_preprint":false},{"pmid":"33439430","id":"PMC_33439430","title":"MicroRNA-24-3p Inhibits Microglia Inflammation by Regulating MK2 Following Spinal Cord Injury.","date":"2021","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/33439430","citation_count":22,"is_preprint":false},{"pmid":"31617572","id":"PMC_31617572","title":"Substrate-based kinase activity inference identifies MK2 as driver of colitis.","date":"2019","source":"Integrative biology : quantitative biosciences from nano to macro","url":"https://pubmed.ncbi.nlm.nih.gov/31617572","citation_count":21,"is_preprint":false},{"pmid":"35316673","id":"PMC_35316673","title":"Heat shock protein 60 couples an oxidative stress-responsive p38/MK2 signaling and NF-κB survival machinery in cancer cells.","date":"2022","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/35316673","citation_count":21,"is_preprint":false},{"pmid":"32216812","id":"PMC_32216812","title":"The MK2 pathway is linked to G-CSF, cytokine production and metastasis in gastric cancer: a novel intercorrelation analysis approach.","date":"2020","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32216812","citation_count":20,"is_preprint":false},{"pmid":"29729335","id":"PMC_29729335","title":"Sec6 enhances cell migration and suppresses apoptosis by elevating the phosphorylation of p38 MAPK, MK2, and HSP27.","date":"2018","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/29729335","citation_count":20,"is_preprint":false},{"pmid":"24900358","id":"PMC_24900358","title":"Discovery and Hit-to-Lead Optimization of Non-ATP Competitive MK2 (MAPKAPK2) Inhibitors.","date":"2011","source":"ACS medicinal chemistry letters","url":"https://pubmed.ncbi.nlm.nih.gov/24900358","citation_count":19,"is_preprint":false},{"pmid":"25410865","id":"PMC_25410865","title":"p38MAPK and MK2 pathways are important for the differentiation-dependent human papillomavirus life cycle.","date":"2014","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/25410865","citation_count":19,"is_preprint":false},{"pmid":"32647362","id":"PMC_32647362","title":"Phosphorylation of steroid receptor coactivator-3 (SRC-3) at serine 857 is regulated by the p38MAPK-MK2 axis and affects NF-κB-mediated transcription.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32647362","citation_count":19,"is_preprint":false},{"pmid":"30112991","id":"PMC_30112991","title":"Novel Therapeutic Potential of Mitogen-Activated Protein Kinase Activated Protein Kinase 2 (MK2) in Chronic Airway Inflammatory Disorders.","date":"2019","source":"Current drug targets","url":"https://pubmed.ncbi.nlm.nih.gov/30112991","citation_count":18,"is_preprint":false},{"pmid":"23372691","id":"PMC_23372691","title":"Crucial roles of the protein kinases MK2 and MK3 in a mouse model of glomerulonephritis.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23372691","citation_count":18,"is_preprint":false},{"pmid":"33641361","id":"PMC_33641361","title":"Inhibition of Mitogen-Activated Protein Kinase (MAPK)-Activated Protein Kinase 2 (MK2) is Protective in Pulmonary Hypertension.","date":"2021","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/33641361","citation_count":18,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":50249,"output_tokens":8734,"usd":0.140878,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18471,"output_tokens":4152,"usd":0.098077,"stage2_stop_reason":"end_turn"},"total_usd":0.238955,"stage1_batch_id":"msgbatch_01BbTCMyrRPyhtEq6b1MdwCN","stage2_batch_id":"msgbatch_011dEed5bbxYvTAaQWKJevxu","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2015,\n      \"finding\": \"mTOR controls SASP by differentially regulating translation of MAPKAPK2 (MK2) through 4EBP1; activated MK2 then phosphorylates the RNA-binding protein ZFP36L1 during senescence, inhibiting its ability to degrade transcripts of SASP components.\",\n      \"method\": \"Drug screen, genetic rescue, mTOR inhibitor rapamycin treatment, overexpression of constitutively active ZFP36L1, phosphorylation assays\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (drug screen, genetic rescue, phosphorylation assays) identifying MK2 substrate ZFP36L1 and upstream regulator 4EBP1/mTOR\",\n      \"pmids\": [\"26280535\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"MK2 directly phosphorylates RIPK1 at serine 321 in the TNF signaling pathway, inhibiting RIPK1 kinase activation, blocking its ability to bind FADD/caspase-8, and suppressing RIPK1-dependent apoptosis and necroptosis; a phospho-mimetic S321D RIPK1 mutation limits TNF-induced death.\",\n      \"method\": \"In vitro kinase assay, phospho-mimetic mutagenesis (S321D), Co-IP, cell death assays\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct in vitro phosphorylation assay, mutagenesis, replicated across three independent labs (PMIDs 28506461, 28920954, 28920952)\",\n      \"pmids\": [\"28506461\", \"28920954\", \"28920952\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"MK2 is activated by p38 MAPKα and -β, which bind to a basic docking motif in the C terminus of MK2 and phosphorylate its regulatory sites; upon activation, MK2 is exported from nucleus to cytoplasm and cotransports active p38 MAPK. MK2 stabilizes p38 MAPK protein levels through its C terminus (independent of catalytic activity). TNF biosynthesis requires MK2 catalytic activity. Cell migration requires both MK2 catalytic activity and its proline-rich N-terminal region.\",\n      \"method\": \"MK2 knockout macrophages and MEFs, MK2 isoform/mutant reconstitution, p38 MAPK protein level measurement, TNF production assay, cell migration assay on fibronectin\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout with reconstitution of multiple MK2 mutants, multiple orthogonal readouts (p38 stabilization, TNF biosynthesis, migration)\",\n      \"pmids\": [\"12052889\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"MK2 phosphorylates tristetraprolin (TTP) at S52/S178, decreasing TTP's affinity to AU-rich elements (AREs), inhibiting TTP's ability to replace HuR on target mRNAs, and permitting HuR-mediated initiation of translation of TNF mRNA; this exchange between TTP and HuR provides a reversible switch between unstable/non-translatable and stable/efficiently translated mRNAs.\",\n      \"method\": \"ARE reporter assays, TTP/HuR binding experiments, phosphorylation-site mutagenesis, MK2 knockout macrophages\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — biochemical reconstitution of TTP-HuR exchange, phosphorylation site mutagenesis, genetic knockout validation\",\n      \"pmids\": [\"23028373\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"MAPKAPK2 (MK2) and MAPKAPK3 (MK3) phosphorylate Beclin 1 at serine 90 to positively regulate starvation-induced autophagy; BCL2 blocks MK2/MK3-dependent Beclin 1 S90 phosphorylation and thereby inhibits autophagy.\",\n      \"method\": \"In vitro kinase assay, phospho-site mutagenesis, autophagy flux assays in vitro and in vivo, BCL2 co-expression experiments\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct in vitro phosphorylation of Beclin 1 by MK2, mutagenesis of S90, validated in vivo\",\n      \"pmids\": [\"25693418\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"MK2 activity is required for the p38-driven induction of miR-34c following DNA damage; miR-34c in turn represses c-Myc translation to prevent inappropriate DNA replication. In p53-deficient cells, the p38 MAPK/MK2 pathway drives miR-34c induction.\",\n      \"method\": \"MK2 inhibition/knockdown, miR-34c induction measurement, S-phase arrest assays, c-Myc depletion epistasis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological and genetic inhibition of MK2, miRNA epistasis, single lab with multiple readouts\",\n      \"pmids\": [\"20212154\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Crystal structure of the MK2 kinase domain in complex with a high-affinity inhibitor (IC50 8.5 nM) was determined in two crystal forms, revealing conformational flexibility in the binding site and a potential intermediate state during substrate phosphorylation.\",\n      \"method\": \"X-ray crystallography (soaking and co-crystallization), two crystal forms\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure determination in two independent crystal forms with functional implications for substrate binding\",\n      \"pmids\": [\"17449059\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Crystal structure of MK2 kinase domain with pyrrolopyridine inhibitor class defined the ATP binding site and provided structural basis for selective inhibition; inhibitors suppress TNF-α production and show efficacy in acute inflammation models.\",\n      \"method\": \"X-ray crystallography of MK2/inhibitor complex, in vitro kinase assays, cellular TNF-α suppression assays\",\n      \"journal\": \"Journal of medicinal chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure of MK2-inhibitor complex, biochemical and cellular validation\",\n      \"pmids\": [\"17480064\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"MK2 phosphorylates PDE4A5 at Ser147 within the UCR1 domain; this phosphorylation does not alter PDE4A5 basal activity but markedly attenuates PDE4A5 activation by protein kinase A, amplifying intracellular cAMP accumulation. MK2 phosphorylation also triggers a conformational change in PDE4A5 that disrupts its interaction with DISC1 and AIP.\",\n      \"method\": \"In vitro kinase assay, phosphorylation site mutagenesis, MK2/3-null macrophage reconstitution, cAMP accumulation assays, co-IP for protein interactions\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct in vitro kinase assay with mutagenesis, validated in MK2/3-null primary macrophages, multiple orthogonal readouts\",\n      \"pmids\": [\"21323643\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"MK2 phosphorylates CEP131 at S47 and S78 following UV-induced stress; phosphorylation creates direct binding sites for 14-3-3 proteins, which sequester CEP131 in the cytoplasm, blocking formation of new centriolar satellites and causing rapid depletion of these structures.\",\n      \"method\": \"Phosphoproteomics, in vitro kinase assay, phospho-site mutagenesis of CEP131, 14-3-3 binding assays, live-cell imaging of centriolar satellite remodeling\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro kinase assay, phospho-site mutagenesis, direct 14-3-3 binding, functional centriolar satellite imaging\",\n      \"pmids\": [\"26616734\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"MK2 phosphorylates the RNA-binding subunit of the NELF complex, NELFE, at Serine 115 following UV-induced DNA damage; NELFE phosphorylation promotes recruitment of 14-3-3 proteins and rapid dissociation of the NELF complex from chromatin, accompanied by RNA polymerase II elongation.\",\n      \"method\": \"Quantitative phosphoproteomics, kinase inhibition, in vitro phosphorylation, 14-3-3 binding assays, chromatin fractionation, RNA Pol II elongation assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — quantitative phosphoproteomics, direct kinase assay, 14-3-3 binding, chromatin dissociation assays in single comprehensive study\",\n      \"pmids\": [\"29523821\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"MK2 directly phosphorylates keratins K18 at Ser52 and K20 at Ser13 in vitro and in vivo; p38 directly phosphorylates K8-Ser73; MK2 and p38 cooperate to phosphorylate epithelial keratins in intestinal epithelia, and MK2-dependent K20-Ser13 phosphorylation regulates mucin secretion.\",\n      \"method\": \"Phosphoproteomics, in vitro kinase assays, MK2/3 knockout mouse cells, small molecule inhibitors, MK2 knockdown in HT29 cells, mucin secretion assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct in vitro kinase assays, validated in MK2/3 KO mouse ileum and MK2 knockdown cells, multiple orthogonal approaches\",\n      \"pmids\": [\"20724476\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"MAPKAPK2 functions in the yolk cell downstream of p38 MAPK to regulate epiboly during zebrafish development by modulating F-actin network activity at the yolk cell margin; loss-of-function (betty boop mutant) causes premature constriction of an F-actin network and blastoderm margin constriction at 50% epiboly.\",\n      \"method\": \"Positional cloning, whole-blastoderm transplants, mRNA microinjection rescue, p38 inhibitor epistasis, calcium imaging, F-actin visualization\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — positional cloning of maternal-effect mutant, rescue by mRNA injection, epistasis with p38 inhibitor, multiple orthogonal methods\",\n      \"pmids\": [\"19282986\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"MK2-dependent phosphorylation of Hsp25 (Ser86) is required for stress-induced disaggregation and insolubilization of Hsp25 oligomers; in MK2-deficient fibroblasts, Hsp25 insolubilization is delayed, 14-3-3 binding is absent, and cells show increased resistance to arsenite, H2O2, and sublethal heat shock. MK2 phosphorylation of Hsp25 correlates with stress-induced cell damage under sublethal conditions.\",\n      \"method\": \"MK2 knockout fibroblasts, in vitro phosphorylation, 14-3-3 binding assays, GFP-Hsp25 imaging, apoptosis assays, solubility fractionation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout with in vitro biochemistry, multiple stress conditions, imaging and biochemical fractionation\",\n      \"pmids\": [\"16840785\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"MK2 phosphorylates LSP1 at Ser243 (murine)/Ser252 (human), the major phosphorylation site in its C-terminal F-actin binding region; phosphorylated LSP1 localizes to F-actin-enriched lamellipodia and stabilizes F-actin polarization during neutrophil chemotaxis toward fMLP. MK2-/- neutrophils show only transient rather than persistent F-actin polarization.\",\n      \"method\": \"Phospho-site mutagenesis, phospho-specific antibody generation, immunostaining, F-actin polarization assays in WT and MK2-/- neutrophils, p38 inhibitor SB203580\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — phospho-site mutagenesis and knockout validated in primary neutrophils, single lab\",\n      \"pmids\": [\"17481585\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"MK2 SUMOylation at lysine K339 (by TNF-α stimulus) inhibits MK2 kinase activity and limits HSP27 phosphorylation; loss of the SUMOylation site (MK2-K339R) increases kinase activity, prolongs HSP27 phosphorylation, enhances actin filament remodeling, and alters endothelial cell migration.\",\n      \"method\": \"SUMOylation site mutagenesis (K339R), kinase activity assays, HSP27 phosphorylation, actin filament imaging, EC migration assays, dominant-negative MK2\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — site-directed mutagenesis with functional readouts, single lab, multiple orthogonal cellular assays\",\n      \"pmids\": [\"21131586\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"MK2 regulates mGluR-LTD in the hippocampus; MK2/3 double-knockout mice show impaired mGluR-LTD and deficient endocytosis of GluA1 AMPA receptor subunits, with corresponding deficits in hippocampal-dependent spatial reversal learning.\",\n      \"method\": \"MK2/3 double-knockout mice, electrophysiological LTD recordings, GluA1 endocytosis assays, spatial reversal learning behavioral tests\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic knockout with electrophysiology and behavioral phenotyping, single lab\",\n      \"pmids\": [\"25134715\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"MK2 is required for the self-renewal capacity of haematopoietic stem cells (HSCs); MK2-deficient mice have reduced HSC numbers and impaired competitive repopulation. This function requires MK2 interaction with the polycomb group (PcG) complex, as an Edr2-non-binding MK2 mutant fails to rescue the repopulation defect.\",\n      \"method\": \"MK2 knockout mice, competitive repopulation assays, MK2 mutant (Edr2-non-binding) rescue experiments, cell cycle analysis\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic knockout with rescue by wild-type vs. mutant MK2, competitive repopulation assay, single lab\",\n      \"pmids\": [\"19369945\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"A long isoform of MK2 is constitutively translated from an alternative CUG translation initiation site in the 5' UTR of its mRNA, dependent on the RNA helicase eIF4A1. The short (canonical) isoform phosphorylates Hsp27 in vivo, supports cell migration, and stress-induced immediate early gene expression; the long isoform has distinct interaction partners and does not perform these functions.\",\n      \"method\": \"Alternative translation initiation mapping, eIF4A1 inhibition, isoform-specific expression, in vivo Hsp27 phosphorylation assays, migration assays, interaction profiling (MS)\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — biochemical translation mapping and functional isoform comparison with multiple orthogonal assays, single lab\",\n      \"pmids\": [\"31167133\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"MK2 and MK3 are the kinases responsible for phosphorylation of TTP at S52/S178 in LPS-stimulated macrophages; these phosphorylations stabilize TTP protein but release ARE-containing mRNAs from translational repression and inhibit their nucleolytic degradation. MK2/3 also contribute to de novo synthesis of TTP.\",\n      \"method\": \"MK2 KO, MK3 KO, MK2/3 double KO macrophages, TTP phospho-site knock-in (TTPaa) mice, cytokine measurement, mRNA stability assays\",\n      \"journal\": \"Biochemical pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple genetic knockout and knock-in models, multiple cytokine readouts, replicated across labs\",\n      \"pmids\": [\"20599781\", \"31527197\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"BMP-2-induced cell migration requires activation of the p38/MK2/Hsp25 pathway downstream of BMP receptors; genetic ablation of either p38α or MK2 blocks downstream effector activation and BMP-2-induced cell migration. Phosphorylated Hsp25 colocalizes with BMP receptor complexes in lamellipodia; a phosphorylation-null Hsp25 mutant abolishes BMP-2-induced migration.\",\n      \"method\": \"p38α and MK2 genetic ablation (MEFs), kinase activity assays, immunofluorescence of phospho-Hsp25 localization, overexpression of phospho-null Hsp25, cell migration assays\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic ablation with phospho-null mutagenesis and localization studies, single lab\",\n      \"pmids\": [\"21297993\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase required for TGFβ-mediated MMP-2 activation and cell invasion in prostate cancer; dominant-negative MAPKAPK2 blocks HSP27 phosphorylation, and either dominant-negative MAPKAPK2 or non-phosphorylatable HSP27 blocks TGFβ-mediated MMP-2 activity and invasion.\",\n      \"method\": \"Transient transfection of wild-type, constitutively active, and dominant-negative MAPKAPK2; non-phosphorylatable HSP27 mutant; siRNA knockdown; MMP-2 activity assays; invasion assays\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — dominant-negative and siRNA approaches with functional readouts, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"16407830\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The p38 MAPK/MAPKAPK2 signaling pathway regulates urokinase plasminogen activator (uPA) mRNA stability through AU-rich elements in its 3'-UTR in invasive breast cancer cells; the pathway is activated via Rac1-MKK3-p38-MAPKAPK2.\",\n      \"method\": \"Dominant-negative Rac1, constitutively active MKK3/MKK6 mutants, dominant-negative MKK3, beta-globin reporter with uPA 3'-UTR/ARE-deleted 3'-UTR, mRNA stability assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reporter assays with ARE deletion, epistasis with dominant negatives, single lab\",\n      \"pmids\": [\"12377770\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"MK2 regulates TNF-α-induced ICAM-1 and IL-8 expression via phosphorylation of tristetraprolin (TTP) in human pulmonary microvascular endothelial cells; MK2 silencing reduces ICAM-1 and IL-8 mRNA half-lives and decreases TTP phosphorylation, while TTP silencing stabilizes these mRNAs.\",\n      \"method\": \"MK2 siRNA knockdown, TTP siRNA knockdown, mRNA stability assays (half-life measurement), TTP phosphorylation immunoblotting\",\n      \"journal\": \"American journal of physiology. Lung cellular and molecular physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA epistasis with mRNA stability readout, single lab, two orthogonal knockdown strategies\",\n      \"pmids\": [\"22268119\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"MK2 promotes SRC-3 (steroid receptor coactivator-3) phosphorylation at Ser857 via the p38MAPK-MK2 axis; this phosphorylation drives nuclear translocation of SRC-3 and enhances NF-κB-mediated IL-6 transcription.\",\n      \"method\": \"p38MAPK-MK2 pathway inhibition, phospho-site analysis, nuclear translocation assays, NF-κB reporter assays, IL-6 transcription measurement\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pathway inhibition with phospho-site and nuclear localization readouts, single lab\",\n      \"pmids\": [\"32647362\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"MK2 phosphorylates p47phox at Ser329, enhancing NADPH oxidase activation and superoxide production in neutrophils; MK2-deficient neutrophils show reduced p47phox phosphorylation and lower superoxide generation in response to C5a.\",\n      \"method\": \"MK2-/- mice, myeloid-specific MK2 KO (MK2Lyz2-KO), Ser329 phosphorylation site identification, superoxide production assays, NADPH oxidase activity measurement\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic knockout with phospho-site identification, single lab with two KO models\",\n      \"pmids\": [\"30483268\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"FIRINOX chemotherapy triggers autocrine TNFα signaling that activates TAK1→MK2→Hsp27 axis in PDAC; MK2 directly phosphorylates Hsp27 to confer chemoresistance. MK2 inhibition blocks Hsp27 activation, sensitizes PDAC to apoptosis, and suppresses protective autophagy in part by blocking Beclin1 phosphorylation.\",\n      \"method\": \"Reverse-phase protein array, siRNA knockdown, MK2 inhibitor (ATI-450), in vitro kinase assays, autochthonous PDAC mouse model, Beclin1 phosphorylation assays\",\n      \"journal\": \"Science translational medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reverse-phase protein array plus mechanistic follow-up with kinase assays, validated in autochthonous mouse model with multiple orthogonal methods\",\n      \"pmids\": [\"34851698\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"The p38/MK2 complex phosphorylates MFF1 (mitochondrial fission factor 1) at S155, leading to VDAC1 oligomerization and mitochondrial membrane pore formation through which HSP60 is released; cytosolic HSP60 then activates the IKK complex to induce NF-κB-dependent survival gene expression.\",\n      \"method\": \"MFF1 phosphorylation site mutagenesis, VDAC1 oligomerization assays, HSP60 release measurement, IKK complex co-IP, NF-κB reporter assays, mouse xenograft model\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — site mutagenesis with multiple mechanistic readouts, single lab\",\n      \"pmids\": [\"35316673\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The p38-MK2 axis directly phosphorylates E2F1 at Ser-364 in vitro and mediates epirubicin-induced E2F1 induction, which in turn drives FOXM1 expression. MK2 also limits JNK induction by epirubicin, and JNK represses FOXM1 expression.\",\n      \"method\": \"In vitro phosphorylation assay (MK2 phosphorylates E2F1 at Ser-364), siRNA knockdown, MK2-/- MEFs, pharmacological inhibitors, transfection with E2F1 Ser-364 mutants\",\n      \"journal\": \"Molecular cancer research : MCR\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct in vitro phosphorylation confirmed plus genetic KO and mutagenesis, single lab\",\n      \"pmids\": [\"22802261\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"MK2 is required for TGFβ-induced myofibroblast differentiation (smooth muscle alpha-actin upregulation); in MK2-/- MEFs, TGFβ causes downregulation rather than upregulation of smooth muscle alpha-actin, associated with reduced smalpha mRNA stability rather than altered promoter activity.\",\n      \"method\": \"MK2 knockout MEFs, TGFβ stimulation, smalpha expression analysis, mRNA stability assays, serum-responsive promoter reporter assays\",\n      \"journal\": \"Journal of cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with mRNA stability readout, single lab\",\n      \"pmids\": [\"17163490\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"MK2 promotes M2 macrophage polarization and tumor angiogenesis; whole-animal and myeloid-specific MK2 KO demonstrates that MK2 activity in the myeloid compartment supports tumor neoangiogenesis and drives polarization of tumor-associated macrophages into protumorigenic, proangiogenic M2-like macrophages.\",\n      \"method\": \"Whole-animal and tissue-specific (myeloid) MK2 KO mice, tumor growth assays, macrophage polarization assays, angiogenesis assays, MK2 chemical inhibition in human cell lines\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — tissue-specific KO mice with cellular mechanistic follow-up, single lab\",\n      \"pmids\": [\"29666270\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Mesenchymal MK2 drives intestinal carcinogenesis through phosphorylation of Hsp27, which affects downstream tumorigenic effector molecules controlling epithelial proliferation, apoptosis, and angiogenesis; deletion of MK2 in intestinal mesenchymal cells reduces tumor multiplicity and growth in the Apcmin/+ model.\",\n      \"method\": \"Conditional (mesenchymal, epithelial, endothelial) MK2 KO mice, Apcmin/+ model, colitis-associated carcinogenesis model, Hsp27 phosphorylation analysis, tumor growth/invasion assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-type-specific conditional KO in two cancer models with mechanistic Hsp27 phosphorylation readout, multiple orthogonal lines of evidence\",\n      \"pmids\": [\"29844172\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"p38α is required for MAPKAPK2 (MK2) protein expression; in p38α-null fibroblasts and embryonic extracts, MK2 expression is greatly reduced and is restored by re-introduction of p38α.\",\n      \"method\": \"p38α knockout cell lines, embryonic extracts from p38α-null mice, p38α re-introduction rescue, immunoblotting for MK2\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with rescue in multiple models, single lab\",\n      \"pmids\": [\"16198317\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"In HPV-positive cells, p38 and MK2 are phosphorylated and relocalize to the cytoplasm; pharmacological inhibition of MK2 or p38 blocks HPV genome amplification, identifying the p38/MK2 pathway as a key regulator of the HPV differentiation-dependent life cycle.\",\n      \"method\": \"MK2 and p38 inhibitor treatment, HPV genome amplification assays, subcellular localization analysis\",\n      \"journal\": \"Journal of virology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — pharmacological inhibition only, no direct substrate identification, single lab\",\n      \"pmids\": [\"25410865\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"MAPKAPK2 (MK2) is a stress-activated serine/threonine kinase that functions directly downstream of p38 MAPKα/β, which bind to a C-terminal docking motif and phosphorylate MK2's regulatory sites; upon activation, MK2 translocates from nucleus to cytoplasm (co-exporting p38) and phosphorylates a broad substrate spectrum including: TTP/ZFP36L1 (inhibiting mRNA degradation and releasing ARE-containing mRNAs including TNF for translation), Hsp27/Hsp25 (remodeling actin cytoskeleton and modulating stress granule formation), RIPK1 at S321 (suppressing TNF-induced apoptosis and necroptosis), Beclin 1 at S90 (promoting autophagy), CEP131 at S47/S78 (triggering 14-3-3-dependent centriolar satellite remodelling), NELFE at S115 (causing NELF complex dissociation from chromatin and RNA Pol II elongation), keratins K18-S52 and K20-S13, LSP1 at S243 (stabilizing F-actin polarization in neutrophils), PDE4A5 at S147 (attenuating cAMP desensitization), and E2F1 at S364; MK2 additionally stabilizes p38 protein levels through its C-terminus independent of kinase activity and requires its proline-rich N-terminal region for cell migration but its catalytic activity for cytokine production.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"MAPKAPK2 (MK2) is a stress-activated serine/threonine kinase that operates as the principal downstream effector of p38 MAPK, integrating inflammatory, genotoxic, and mechanical stress signals into control of mRNA stability, cytoskeletal dynamics, cell death, and autophagy [#2, #3]. p38 MAPK\\u03b1/\\u03b2 bind a basic docking motif in the MK2 C-terminus and phosphorylate its regulatory sites, triggering nuclear export of MK2 together with active p38; MK2 also stabilizes p38 protein levels through a C-terminal interaction that is independent of its catalytic activity, while p38\\u03b1 reciprocally is required for MK2 protein expression [#2, #32]. A central MK2 output is post-transcriptional control of inflammatory gene expression: MK2 phosphorylates the ARE-binding proteins tristetraprolin (TTP/ZFP36) at S52/S178 and ZFP36L1, lowering their affinity for AU-rich elements, releasing ARE-containing transcripts such as TNF, ICAM-1, IL-8, and SASP factors from repression and degradation, and permitting HuR-mediated translation [#3, #19, #0, #23]. Through phosphorylation of the small heat-shock protein Hsp27/Hsp25 at S86, MK2 remodels the actin cytoskeleton and modulates stress resistance, driving cell migration downstream of BMP-2 and TGF\\u03b2 and promoting invasion and chemoresistance in cancer [#13, #20, #21, #26]. MK2 directly phosphorylates a broad substrate spectrum that diversifies its biology: RIPK1 at S321 to suppress TNF-induced apoptosis and necroptosis [#1], Beclin 1 at S90 to promote starvation-induced autophagy [#4], CEP131 at S47/S78 and NELFE at S115 to create 14-3-3 docking sites controlling centriolar satellite remodelling and RNA Pol II elongation after UV stress [#9, #10], PDE4A5 at S147 to amplify cAMP signalling [#8], and epithelial keratins K18-S52 and K20-S13 to regulate mucin secretion [#11]. Distinct structural regions and modifications partition these functions \\u2014 the catalytic activity drives cytokine production while a proline-rich N-terminal region is required for migration, and SUMOylation at K339 dampens kinase output [#2, #15]. In vivo, MK2 governs zebrafish epiboly via F-actin at the yolk margin, hematopoietic stem cell self-renewal through a polycomb interaction, hippocampal mGluR-LTD, and tumor-promoting macrophage polarization and stromal signalling [#12, #17, #16, #30, #31].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"Established how MK2 is activated and how its modular architecture partitions distinct outputs, defining MK2 as a p38-controlled effector with separable functions for cytokine production versus migration.\",\n      \"evidence\": \"MK2 knockout macrophages and MEFs with reconstitution of MK2 isoforms/mutants, p38 protein measurement, TNF and migration assays\",\n      \"pmids\": [\"12052889\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not enumerate the full substrate set downstream of activation\", \"Structural basis of the C-terminal docking and p38 stabilization not resolved here\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Showed the MK2\\u2013p38 relationship is mutually stabilizing at the protein level, with p38\\u03b1 required for MK2 expression, framing the pair as an interdependent module.\",\n      \"evidence\": \"p38\\u03b1-null fibroblasts and embryonic extracts with p38\\u03b1 re-introduction rescue, MK2 immunoblotting\",\n      \"pmids\": [\"16198317\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of reciprocal stabilization at molecular level not defined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Resolved the MK2 kinase domain and its ATP/inhibitor-binding site, providing a structural basis for selective inhibition and linking inhibition to suppression of TNF-\\u03b1.\",\n      \"evidence\": \"X-ray crystallography of MK2-inhibitor complexes in two crystal forms, in vitro kinase and cellular TNF-\\u03b1 assays\",\n      \"pmids\": [\"17449059\", \"17480064\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structure of MK2 bound to a physiological substrate\", \"Conformational states during activation not captured\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Demonstrated that MK2 phosphorylation of Hsp25/Hsp27 controls oligomer disaggregation, 14-3-3 binding, and stress resistance, establishing the central cytoskeletal/chaperone branch of MK2 signalling.\",\n      \"evidence\": \"MK2 knockout fibroblasts, in vitro phosphorylation, 14-3-3 binding, GFP-Hsp25 imaging and solubility fractionation under multiple stresses\",\n      \"pmids\": [\"16840785\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream actin-remodeling effectors not fully mapped\", \"Relationship between Hsp25 phosphorylation and cell-fate decisions partly correlative\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Defined the molecular logic of MK2-driven mRNA stabilization by showing MK2 phosphorylation of TTP triggers a TTP-to-HuR exchange that switches transcripts from unstable/untranslated to stable/translated.\",\n      \"evidence\": \"ARE reporter assays, TTP/HuR binding and phospho-site mutagenesis in MK2 knockout macrophages\",\n      \"pmids\": [\"23028373\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo physiological scope of the exchange beyond TNF not fully delineated here\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Genetic knockout/knock-in models identified MK2 and MK3 as the kinases phosphorylating TTP at S52/S178 in vivo, anchoring MK2's role in post-transcriptional control of inflammation.\",\n      \"evidence\": \"MK2 KO, MK3 KO, MK2/3 double-KO macrophages and TTP phospho-site knock-in mice with cytokine and mRNA stability readouts\",\n      \"pmids\": [\"20599781\", \"31527197\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of MK2 versus MK3 across cell types not fully resolved\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Expanded the substrate spectrum into autophagy and stress-response chromatin/organelle control, showing MK2 phosphorylates Beclin 1 (S90), CEP131 (S47/S78), and ZFP36L1 to govern autophagy, centriolar satellites, and SASP.\",\n      \"evidence\": \"In vitro kinase assays, phospho-site mutagenesis, 14-3-3 binding, autophagy flux, live-cell imaging, and senescence/SASP assays\",\n      \"pmids\": [\"25693418\", \"26616734\", \"26280535\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Coordination among these parallel substrate branches in a single cell unclear\", \"Upstream stimulus selectivity for each substrate not defined\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Established MK2 as a direct brake on cell death by phosphorylating RIPK1 at S321 to block its kinase activation and FADD/caspase-8 engagement, suppressing apoptosis and necroptosis.\",\n      \"evidence\": \"In vitro kinase assay, S321D phospho-mimetic mutagenesis, Co-IP, and cell death assays, replicated across three labs\",\n      \"pmids\": [\"28506461\", \"28920954\", \"28920952\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Integration with the cytokine-producing arm of MK2 in the same TNF response not fully reconciled\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Showed MK2 couples DNA-damage stress to transcription by phosphorylating NELFE (S115) to evict the NELF complex and license RNA Pol II elongation via 14-3-3 recruitment.\",\n      \"evidence\": \"Quantitative phosphoproteomics, in vitro phosphorylation, 14-3-3 binding, chromatin fractionation, and Pol II elongation assays\",\n      \"pmids\": [\"29523821\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genome-wide set of MK2-dependent elongation targets not defined\", \"Single comprehensive study\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Demonstrated therapeutic relevance of the MK2\\u2013Hsp27 axis, showing chemotherapy-induced TNF\\u03b1 drives TAK1\\u2192MK2\\u2192Hsp27 signalling and protective autophagy to confer chemoresistance in pancreatic cancer.\",\n      \"evidence\": \"Reverse-phase protein array, siRNA, MK2 inhibitor ATI-450, in vitro kinase and Beclin1 phosphorylation assays in an autochthonous PDAC mouse model\",\n      \"pmids\": [\"34851698\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of Hsp27 versus Beclin1 branches to resistance not separated\", \"Durability of MK2 inhibition not addressed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How MK2 selects among its many substrates in a given stress context, and how isoform, SUMOylation, and subcellular partitioning route signal flow, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model of substrate prioritization under combined stresses\", \"Regulatory role of the long CUG-initiated MK2 isoform incompletely mapped\", \"Structural basis of substrate docking not determined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [1, 3, 4, 8, 9, 10, 11]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [1, 3, 4, 9, 10, 11]},\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [6, 7]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [2, 10]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [2, 9]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [2, 3, 19, 23]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [0, 3, 19, 22]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [1, 26]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [4, 26]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [9, 10, 13]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [10, 28]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"MAPK14\", \"HSPB1\", \"ZFP36\", \"RIPK1\", \"BECN1\", \"CEP131\", \"NELFE\", \"PDE4A5\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}